Scientists call the name "discriminatory and stigmatizing." The World Health Organization agrees. But no progress has been made on finding a new name. And some say the name doesn't need changing.
A lack of funding in core public health programs slowed the response to the ongoing COVID-19 pandemic and exacerbated its impact, according to a new report from Trust for America's Health — and the pattern is repeating in the latest monkeypox outbreak.
Though doctors and advocates have helped speed up access to the antiviral pills – of which the U.S. has enough to treat 1.7 million people – health providers are few and forms are still required.
The country's monkeypox outbreak can still be stopped, U.S. health officials said Thursday, despite rising case numbers and so far limited vaccine supplies.
The mayor's announcement allows officials to mobilize personnel and resources and cut through red tape to get ahead of a public health crisis reminiscent of the AIDS epidemic that devastated the city.
The number of confirmed monkeypox cases in Georgia has more than doubled since July 15, with 213 confirmed cases as of Monday, with the majority of infections transmitted by skin-to-skin contact by men who had sex with other men.
While the current monkeypox outbreak appears to mostly affect men who have sex with other men, others are still at risk. History and public health experts say it's dangerous to suggest otherwise.
People diagnosed with monkeypox disease shared their experiences Thursday at a town hall meeting hosted by the Fulton County Board of Health and Atlanta Pride.
Men who have sex with men in the metro Atlanta area may be at risk of contracting monkeypox. The Georgia Department of Public Health said Friday there is enough vaccine for 1,500 people.
Since May, when this monkeypox outbreak was discovered, cases have exploded in a short period of time, according to the Georgia Department of Public Health — and are probably undercounted.
The Department of Health and Human Services will make 296,000 doses available in the coming weeks, and expects a total of 1.6 million doses to be available in the U.S. by the end of the year.
